Related Experiment Video
Updated: Oct 16, 2025

04:24
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
12.0K
Development of a computer-aided text message platform for user engagement with a digital Diabetes Prevention Program:
Danissa V Rodriguez1, Katharine Lawrence1, Son Luu1
1Department of Population Health, NYU Grossman School of Medicine, New York, New York, USA.
Journal of the American Medical Informatics Association : JAMIA
|October 19, 2021
Summary
Personalized automatic message systems (PAMS) enhance engagement in digital diabetes prevention programs (dDPP) by sending tailored messages from primary care providers. This improves adherence and health outcomes for diabetes prevention efforts.
Area of Science:
- Digital health
- mHealth applications
- Behavioral science
Background:
- Digital Diabetes Prevention Programs (dDPP) show clinical effectiveness but struggle with long-term user engagement.
- Poor adherence to dDPP hinders meaningful health outcomes in diabetes prevention.
- Integrating technology into clinical workflows is crucial for sustained digital health interventions.
Purpose of the Study:
- To design and develop a Personalized Automatic Message System (PAMS) to boost user engagement with dDPP platforms.
- To create a system that sends automated, tailored messages from primary care providers to dDPP users.
- To address the challenge of long-term adherence in digital diabetes prevention.
Main Methods:
- Employed user-centered design (UCD) methodologies, including focus groups, interviews, and workshops, to define system requirements.
- Developed PAMS using computational tools to deliver theory-based, automated, and tailored messages and content.
- Integrated PAMS into existing clinical workflows for seamless delivery of support.
- Conducted preliminary user testing to evaluate system feasibility and user reception.
Main Results:
- Key requirements and features for PAMS were identified through iterative UCD cycles.
- A technical architecture and build for PAMS were successfully developed.
- Preliminary user testing indicated positive reception and potential for enhanced dDPP engagement.
- The system demonstrated the capability to deliver automated, tailored content via messages.
Conclusions:
- PAMS offers an innovative solution to improve long-term engagement in dDPP.
- Integrating automated, personalized messaging into clinical workflows can support diabetes prevention efforts.
- User-centered design is critical for developing effective mHealth interventions like PAMS.
- Further research and testing are warranted to confirm the impact of PAMS on adherence and health outcomes.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
3.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.3K
Diabetes Mellitus: Overview and Type I Subtype
3.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.7K
Diabetes: Management and Pharmacotherapy
566
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
566

